This text is a result of machine translation.
F-star to be acquired by China biopharmaceutical with USD 161million
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
The investment banking business was strictly supervised, and seven securities companies received fines
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Amazon: the policy is consistent all over the world, and the title is not for Chinese businesses
Zhang Kun's four funds decreased their positions in the second quarter by allocating Wuliangye to Guizhou Maotai
Thinking of ASEAN as a single market is the biggest miscalculation for Chinese companies
Feb 19, 2026 12:00 PM
You're Invited: China's Innovation, Up Close
Feb 10, 2026 04:21 PM
CES 2026 in Numbers | From Shenzhen to Las Vegas: Huaqiangbei’s Year-End Report
Jan 15, 2026 09:42 PM